Vicarious Surgical EBITDA 2021-2024 | RBOT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vicarious Surgical ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vicarious Surgical ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$212.6B
Intuitive Surgical (ISRG)	$186.7B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.5B
Edwards Lifesciences (EW)	$38.8B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$26.9B
Waters (WAT)	$22.9B
SONOVA HOLDING (SONVY)	$22B
STERIS (STE)	$21.3B
Hologic (HOLX)	$18.4B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Sysmex ADR (SSMXY)	$12.4B
Globus Medical (GMED)	$11.1B
Teleflex (TFX)	$9.2B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.6B
Glaukos (GKOS)	$7.7B
PROCEPT BioRobotics (PRCT)	$5B
Integer Holdings (ITGR)	$4.5B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
Veracyte (VCYT)	$2.9B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.2B
Integra LifeSciences Holdings (IART)	$2B
RxSight (RXST)	$1.9B
Alphatec Holdings (ATEC)	$1.3B